75
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Prospects and Problems of Direct-tgo-Public Genetic Tests

Pages 511-520 | Published online: 09 Sep 2008

Bibliography

  • Yoon PW , ChenB, FaucettA et al.: Public health impact of genetic tests at the end of the 20th century. Genet. Med.3 , 405–410 (2001).
  • Adeoye S , BozicKJ: Direct to consumer advertising in healthcare: history, benefits and concerns.Clin. Orthop. Relat. Res.457 , 96–104 (2007).
  • Ling D , BerndtE, KyleM: Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter sales.J. Law Econ.45 , 691–723 (2002).
  • Wilkes MS , BellRA, KravitzRL: Direct-to-consumer prescriptions drug advertising: trends, impact, and implications.Health Aff. (Millwood)19 , 110–128 (2000).
  • Lyles DC : Direct marketing of pharmaceuticals to consumers.Annu. Rev. Public Health23 , 73–91 (2002).
  • Donohue JM , CevascoM, RosenthalMB: A decade of direct-to-consumer advertising of prescription drugs.N. Engl. J. Med.357 , 673–681 (2007).
  • Prescription Drug User Fee Act: Adding Resources and Improving Performance in FDA Review of New Drug Applications. US FDA, Washington, DC, USA (2005).
  • Schein D : Liability for adverse events in direct-to-consumer advertising.JAMA289 , 2646 (2003).
  • Henney JE : MSJAMA: challenges in regulating direct-to-consumer advertising.JAMA284 , 2242 (2000).
  • Kravitz RL : Direct-to-consumer advertising of prescription drugs: implications for the patient–physician relationship.JAMA284(17) , 2244 (2000).
  • Lipsky MS , TaylorCA: The opinions and experiences of family physicians regarding direct-to-consumer advertising.J. Fam. Pract.45 , 495–499 (1997).
  • Sellers JA : The two faces of direct-to-consumer advertising.Am. J. Health-Syst. Pharmacy57 , 1401 (2000).
  • Holmer AF : Direct-to-consumer advertising: education or anathema?JAMA282 , 1226–1227 (1999).
  • Calfee JE : An assessment of direct-to-consumer advertising of prescription drugs.Clin Pharm Ther.82 , 357–360 (2007).
  • Hoffman JR , WilkesM: Direct to consumer advertising of prescription drugs: an idea whose time should not come.BMJ218 , 1301–1302 (1999).
  • grave;t Hoen E : Direct-to-consumer advertising: for better profits or better health?Am. J. Health-Syst. Pharmacy55 , 594–597 (1998).
  • Bell RA , KravitzRL, WilkesMS: Direct-to-consumer prescription drug advertising and the public.J. Gen. Intern. Med.14651–14657 (1999).
  • Young D : FDA examines direct-to-consumer advertising data.Am. J. Health-Syst. Pharmacy60 , 2420–2421 (2003).
  • Gollust SE , HullSC, WilfondBS: Limitations of direct-to-consumer advertising for clinical genetic testing.JAMA288 , 1762–1767 (2002).
  • Hull SC , PrasadK: Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.Reprod. Health Matters9 , 44–48 (2001).
  • Mouchawar J , Hensley-AlfordS, LaurionS et al.: Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally occurring experiment. Genet. Med.7 , 191–197 (2005).
  • Tracy E : Are doctors prepared for direct-to-consumer advertising of genetics tests?Obstet. Gynecol.110 , 1389–1391 (2007).
  • Mouchawar J , LaurionS, RitzwollerDP et al.: Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Am. J. Mag. Care11 , 601–608 (2005).
  • Gellad ZF , LylesKW: Direct-to-consumer advertising of pharmaceuticals.Am. J. Med.120 , 475–480 (2007).
  • Abel GA , PensonRT, JoffeS et al.: Direct-to-consumer advertising in oncology. Oncologist11 , 217–226 (2006).
  • Murray EM , LoB, PollackL et al.: Direct-to-consumer advertising: physicians views of its effects on quality of care and the doctor–patient relationship. J. Am. Board Fam. Pract.16 , 513–524 (2003).
  • Wilkes MS , BellRA, KravitzRL: Direct-to-consumer prescription drug advertising: trends, impact, and implications.Health Aff. (Millwood)19 , 110–128 (2000).
  • Gollust SE , WilfondBS, HullSC: Direct-to-consumer sales of genetic services on the internet.Genet. Med.5 , 332–337 (2003).
  • Wolfberg AJ : Genes on the web – direct-to-consumer marketing of genetic testing.N. Engl. J. Med.355 , 543–544 (2006).
  • Ingelfinger FJ : Advertising: informational but not educational.N. Engl. J. Med.286 , 1318–1319 (1972).
  • Leacock S : The Garden of Folly. Dodd, Mead & Co., NY, USA, 133–131 (1924).
  • Wolfe SM : Direct-to-consumer advertising – education or emotion promotion?N. Engl. J. Med.346 , 524–526 (2002).
  • Federal Trade Commission Facts for Consumers: At-Home Genetic Test: A Healthy Dose of Skepticism May be the Best Prescription. Federal Trade Commission, Bureau of Consumer Protections, Division of Consumer and Business Education (2006).
  • The direct-to-consumer advertising genie. Lancet369 , 1 (2007).
  • American College of Medicine Genetics Board of Directors: ACMG statement on direct-to-consumer genetic testing. Genet. Med.6 , 60 (2004).
  • Watson MS : Direct to Consumer DNA Testing: Where it Might Fit in Medical Care. Talk given at Massachusetts General Hospital, MA, USA, 10 March 2008.
  • Mintzes B , BarerML, BassettK et al.: An Assessment of the Health System Impacts of Direct-to-Consumer Advertising of Prescription Medicines (DTCAAA) (Volume III). Patient Information on Medicines Comparative Patient/Doctor Survey in Vancouver and Sacramento. University of British Columbia Health Policy Research Unit, Vancouver, Canada (2001).
  • Hollon MF : Direct-to-consumer advertising: a haphazard approach to health promotion.JAMA293 , 2030–2033 (2005).
  • Goelen G , RigoA, BonduelleM, de Grève J: BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients. Ann. NY Acad. Sci.889 , 240–243 (1999).
  • Vogel VG , CostantinoJP, WickerhamDL et al.: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA295 , 2727–2741 (2006).
  • Mann GB , BorgenPI: Breast cancer genes and the surgeon.J. Surg. Oncol.67 , 267–274 (1998).
  • American College of Obstetricians and Gynecologists: Committee opinion: update on carrier screening for cystic fibrosis. Obstet. Gynecol.325 , 1–5 (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.